Cargando…

PDGFRA, HSD17B4 and HMGB2 are potential therapeutic targets in polycystic ovarian syndrome and breast cancer

To explore the key genes associated with both PCOS and breast cancer, we overlapped the synchronously differently expressed genes in two obese insulin-resistant GEO datasets in muscle tissue and genes exert essential roles in breast cancer prognosis together base on the following reasons: (1) Androg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Huiyu, Han, Yong, Lou, Jiaying, Zhang, Hongxian, Zhao, Yue, Győrffy, Balázs, Li, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642496/ https://www.ncbi.nlm.nih.gov/pubmed/29050221 http://dx.doi.org/10.18632/oncotarget.17846

Ejemplares similares

HSD17B13: A Potential Therapeutic Target for NAFLD
por: Zhang, Hai-bo, et al.
Publicado: (2022)

HSD17B12 dosage insufficiency induced premature ovarian insufficiency in humans and mice
por: Wang, Qiqi, et al.
Publicado: (2022)

The role of PDGFRA as a therapeutic target in young colorectal cancer patients
por: Kim, Tae Won, et al.
Publicado: (2021)

THU574 Hsd17b1 Partially Compensates For The Lack Of Hsd17b3 In Testicular Testosterone Production In Fetal Mice, But Not In Adults
por: Poutanen, Matti, et al.
Publicado: (2023)

Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma
por: Lassus, H, et al.
Publicado: (2004)

Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies
por: Ip, Carman K. M., et al.
Publicado: (2018)

Role of PDGFRA(+) cells and a CD55(+) PDGFRA(Lo) fraction in the gastric mesenchymal niche
por: Manieri, Elisa, et al.
Publicado: (2023)

SUN-213 Hsd17b3 Knockout Mice Serve As A Model To Define Mechanisms Behind The Altered Endocrine Phenotype Of Patients With Hsd17b3 Mutations
por: Poutanen, Matti, et al.
Publicado: (2019)

The Obesity-Related Metabolic Gene HSD17B8 Protects Against Breast Cancer: High RNA/Protein Expression Means a Better Prognosis
por: Nie, Yunmeng, et al.
Publicado: (2022)

Effects of Aerobic Exercise on Rats with Hyperandrogenic Polycystic Ovarian Syndrome
por: Li, Na, et al.
Publicado: (2021)

Characterization of 17α-hydroxysteroid dehydrogenase activity (17α-HSD) and its involvement in the biosynthesis of epitestosterone
por: Bellemare, Véronique, et al.
Publicado: (2005)

Genetic Variation in the HSD17B1 Gene and Risk of Prostate Cancer
por: Kraft, Peter, et al.
Publicado: (2005)

Analyses of Molecular Characteristics and Enzymatic Activities of Ovine HSD17B3
por: Islam, Mohammad Sayful, et al.
Publicado: (2021)

The Peroxisomal Localization of Hsd17b4 Is Regulated by Its Interaction with Phosphatidylserine
por: Lee, Sang-Ah, et al.
Publicado: (2021)

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Munkácsy, Gyöngyi, et al.
Publicado: (2023)

Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer
por: Győrffy, Balázs
Publicado: (2023)

Association Analysis between the Polymorphisms of HSD11B1 and H6PD and Risk of Polycystic Ovary Syndrome in Chinese Population
por: Ju, Rong, et al.
Publicado: (2015)

Hydroxybenzothiazoles as New Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1)
por: Spadaro, Alessandro, et al.
Publicado: (2012)

Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target
por: Motomura, Takashi, et al.
Publicado: (2021)

An overview of agents and treatments for PDGFRA-mutated gastrointestinal stromal tumors
por: Sun, Yingchao, et al.
Publicado: (2022)

Transcription start sites and epigenetic analysis of the HSD17B10 proximal promoter
por: Yang, Song-Yu, et al.
Publicado: (2013)

Acetylation-mediated degradation of HSD17B4 regulates the progression of prostate cancer
por: Huang, Huichao, et al.
Publicado: (2020)

Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors
por: Gao, Jing, et al.
Publicado: (2016)

ERBB4 promotes the progression of inflammatory breast cancer through regulating PDGFRA
por: Gong, Ni, et al.
Publicado: (2020)

CDK4/6 and PDGFRA Signaling as Therapeutic Targets in Diffuse Intrinsic Pontine Glioma
por: Hoeman, Christine, et al.
Publicado: (2018)

Differential but Concerted Expression of HSD17B2, HSD17B3, SHBG and SRD5A1 Testosterone Tetrad Modulate Therapy Response and Susceptibility to Disease Relapse in Patients with Prostate Cancer
por: Bamodu, Oluwaseun Adebayo, et al.
Publicado: (2021)

Insights in 17β-HSD1 Enzyme Kinetics and Ligand Binding by Dynamic Motion Investigation
por: Negri, Matthias, et al.
Publicado: (2010)

The effects of dexamethasone on 17 [Formula: see text]-HSD1 levels at the rat optic nerve
por: Liu, Chuanzhi, et al.
Publicado: (2019)

Biallelic mutation of HSD17B4 induces middle age–onset spinocerebellar ataxia
por: Matsuda, Yukiko, et al.
Publicado: (2020)

Comparison of Placental HSD17B1 Expression and Its Regulation in Various Mammalian Species
por: Yazawa, Takashi, et al.
Publicado: (2023)

Targeting macrophagic 17β-HSD7 by fenretinide for the treatment of nonalcoholic fatty liver disease
por: Dong, Xiaoyu, et al.
Publicado: (2023)

The Role of PDGFRA in Predicting Oncological and Immune Characteristics in Pancreatic Ductal Adenocarcinoma
por: Wu, Zijian, et al.
Publicado: (2022)

Metanephric stromal tumor in an adult with PDGFRA mutation: a case report
por: Guo, Sanjun, et al.
Publicado: (2023)

Xp11.22 duplications in four unrelated Chinese families: delineating the genotype-phenotype relationship for HSD17B10 and FGD1
por: Wang, Qingming, et al.
Publicado: (2020)

Pathological complete response of HER2-positive breast cancer to trastuzumab and chemotherapy can be predicted by HSD17B4 methylation
por: Fujii, Satoshi, et al.
Publicado: (2017)

Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy
por: Dong, Haonan, et al.
Publicado: (2022)

Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient
por: Negri, T, et al.
Publicado: (2007)

Succinate dehydrogenase deficiency in a PDGFRA mutated GIST
por: Belinsky, Martin G., et al.
Publicado: (2017)

Heterozygous mutations in HSD17B4 cause juvenile peroxisomal D-bifunctional protein deficiency
por: Amor, David J., et al.
Publicado: (2016)

Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
por: Lv, Lei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e9tqj8q674dkpqtr7nsgkc5gt9